Company Description
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States.
The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.
It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
| Country | United States |
| Founded | 2003 |
| IPO Date | Sep 15, 2020 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 310 |
| CEO | Leslie Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California 95134 United States | |
| Phone | 669 231 8200 |
| Website | outsetmedical.com |
Stock Details
| Ticker Symbol | OM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $27.00 |
| CIK Code | 0001484612 |
| CUSIP Number | 690145206 |
| ISIN Number | US6901452069 |
| Employer ID | 20-0514392 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Leslie L. Trigg | President, Chief Executive Officer and Chairman |
| James S. Mazzola | Vice President of Corporate Communications and Investor Relations |
| Amelia Merrill | Vice President of People Operations and Culture |
| Dr. Michael Aragon M.D. | Chief Medical Officer |
| Dinamarie Stefani | Senior Vice President of Regulatory Affairs and Quality Assurance |
| Brittni McGill | Chief Nursing Officer |
| Brett Fogg | Senior Vice President of Research & Development and Operations |
| Derick Elliott | Executive Vice President of Commercial |
| John Geraci | Vice President and Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 24, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2026 | SCHEDULE 13G/A | Filing |
| Feb 17, 2026 | 144 | Filing |
| Feb 17, 2026 | 144 | Filing |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 17, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Feb 13, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Feb 13, 2026 | 10-K | Annual Report |